Not applicableUnknownNCT03870802What this trial is testingMACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)Who this might be right forBreast Cancer Centre Leon Berard 40
Not applicableStudy completedNCT01938014What this trial is testingLysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool ChildrenWho this might be right forMucopolysaccharidosis Type I (MPS I)Mucopolysaccharidosis Type II (MPS II)Mucopolysaccharidosis Type III (MPS III)+2 more University of Chicago 19
Not applicableLooking for participantsNCT06698887What this trial is testingEvaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in KoreaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 15
Not applicableNot Yet RecruitingNCT07341178What this trial is testingAcute Effects on Stem Cell SurveillanceWho this might be right forStem Cell Surveillance Natural Immune Systems Inc 48
Not applicableStudy completedNCT07142720What this trial is testingRapid Effects on Antioxidant Status, Immune Alertness, and Regenerative ActivityWho this might be right forImmune SurveillanceStem Cell Surveillance Natural Immune Systems Inc 20
Not applicableLooking for participantsNCT07127705What this trial is testingRapid Response of Stem Cells and Immune Cells for EfficacyWho this might be right forStem Cell Surveillance Natural Immune Systems Inc 24
Not applicableStudy completedNCT00667303What this trial is testingProspective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell TransplantationWho this might be right forRespiratory Virus Infections St. Jude Children's Research Hospital 51
Not applicableStudy completedNCT00026767What this trial is testingSurveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant RecipientsWho this might be right forFungus Disease National Cancer Institute (NCI) 217
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03167203What this trial is testingA Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell TherapyWho this might be right forMacular Degenerative Disease Astellas Institute for Regenerative Medicine 36